Results 311 to 320 of about 234,996 (348)
Some of the next articles are maybe not open access.
Obstetrical & Gynecological Survey, 2020
(Abstracted from N Engl J Med 2020;383:2053–2064) Incidence rates and associated mortality of endometrial cancer continue to rise in the United States, including a sustained rise in cases among women younger than 50 years. This trend is partially driven by the rising rates of obesity, one of the most important risk factors for this disease.
Karen H, Lu, Russell R, Broaddus
openaire +4 more sources
(Abstracted from N Engl J Med 2020;383:2053–2064) Incidence rates and associated mortality of endometrial cancer continue to rise in the United States, including a sustained rise in cases among women younger than 50 years. This trend is partially driven by the rising rates of obesity, one of the most important risk factors for this disease.
Karen H, Lu, Russell R, Broaddus
openaire +4 more sources
Obstetrics & Gynecology, 2008
This review summarizes the epidemiology, prevention, diagnosis and treatment, and prognosis of endometrial carcinoma. Although the incidence of disease has remained stable, the death rate has increased over 100% over the last two decades. Precursor lesions of complex hyperplasia with atypia are associated with an endometrial carcinoma in over 40% of ...
Alexey Davydov, V. Craig Jordan
openaire +4 more sources
This review summarizes the epidemiology, prevention, diagnosis and treatment, and prognosis of endometrial carcinoma. Although the incidence of disease has remained stable, the death rate has increased over 100% over the last two decades. Precursor lesions of complex hyperplasia with atypia are associated with an endometrial carcinoma in over 40% of ...
Alexey Davydov, V. Craig Jordan
openaire +4 more sources
International Journal of Gynecological Cancer, 1999
Endometrial cancer is the most common gynecologic malignancy in the United States, with 37,400 new cases and 6400 deaths estimated to occur in 1999. The epidemiology of endometrial cancer has been widely characterized; nevertheless, efforts continue to more precisely define risk factors for the disease.
openaire +4 more sources
Endometrial cancer is the most common gynecologic malignancy in the United States, with 37,400 new cases and 6400 deaths estimated to occur in 1999. The epidemiology of endometrial cancer has been widely characterized; nevertheless, efforts continue to more precisely define risk factors for the disease.
openaire +4 more sources
Oncology Research and Treatment, 2003
Radical surgery including complete pelvic and para-arortic lymph node dissection (LND) is both the main therapeutic effort and the decisive staging procedure in patients with invasive endometrial cancer (EC) and should be performed in specialized institutions.
V, Hanf, A R, Günthert, G, Emons
openaire +2 more sources
Radical surgery including complete pelvic and para-arortic lymph node dissection (LND) is both the main therapeutic effort and the decisive staging procedure in patients with invasive endometrial cancer (EC) and should be performed in specialized institutions.
V, Hanf, A R, Günthert, G, Emons
openaire +2 more sources
Current Problems in Cancer, 1997
Carcinoma of the uterine corpus (endometrial cancer) remains the gynecologic malignant disease with the highest annual prevalence in the United States. The most common histologic type is adenocarcinoma, although more aggressive variants (e.g., papillary serous carcinoma and clear cell carcinoma) have been identified.
K M, Greven, B W, Corn
openaire +2 more sources
Carcinoma of the uterine corpus (endometrial cancer) remains the gynecologic malignant disease with the highest annual prevalence in the United States. The most common histologic type is adenocarcinoma, although more aggressive variants (e.g., papillary serous carcinoma and clear cell carcinoma) have been identified.
K M, Greven, B W, Corn
openaire +2 more sources
Estrogens and Endometrial Cancer
Journal of Urology, 1980The role of ovarian hormones in endometrial carcinoma was first suspected on the basis of observations of certain endocrine disorders, e.g. polycystic ovary syndrome and hormone secreting ovarian tumors1,2. Recently postmenopausal estrogen therapy became the center of controversy on possible endometrial carcinogenicity3–50.
P Spavento +8 more
openaire +4 more sources